Home/BioArctic AB/Erika Hjerpe
EH

Erika Hjerpe

Chief Operating Officer (COO)

BioArctic AB

BioArctic AB Pipeline

DrugIndicationPhase
Lecanemab (Leqembi®)Early Alzheimer's DiseaseApproved
BAN2802Alzheimer's DiseasePreclinical
BAN2401Parkinson's DiseasePhase 1
BAN0805Parkinson's DiseasePreclinical
Anti-alpha-synuclein Oligomer mAbMultiple System Atrophy (MSA)Discovery
Undisclosed ProgramALSDiscovery